Asia has a long and proud history of innovation and today we live in a world which is characterized by breakne...Read more
Using the function of the individual's own immune system to combat cancer, this out-of-the-box concept was pro...Read more
Filterlex Medical is a medical device start-up company based in Israel, developing an innovative embolic ...Read more
The medical device market in ASEAN is predicted to be worth US$8.5 billion by 2021, and Thai entrepreneurs wan...Read more
Improved regulatory support push Clinical Research in Asia
The prevalence of infectious and tropical diseases is creating an unmet clinical needs in emerging countries. Owing to these, a large number of the population participate in clinical trials to access high-quality healthcare free of cost. India and China have the highest prevalence rates for metabolic disorders, due to the increasing population, combined with the prevalence of insulin resistance, hyperlipidemia, and obesity. Besides the Asian region has the potential for large patient recruitment, cost reduction, the improved regulatory environment making it a favourable destination for clinical trials.